OPEN-SOURCE SCRIPT
ES/NQ Execution System v2 (Scaling + Risk + Trailing) by Lincoln
What this version actually does.
1. Real trade lifecycle now exists
Instead of:
enter → exit
Now:
entry → 1R → breakeven → 2R → trail runner
This is how real discretionary + systematic hybrids operate.
2. You are no longer dependent on perfect exits
first target locks profit
second target scales performance
runner adapts to trend continuation
3. Risk becomes stable over time
stop is fixed per trade
no emotional adjustment
trailing only activates after profit
4. Works best on:
ES 5m = smoother scaling
NQ 5m = stronger runner potential
15m = directional bias overlay (recommended above this)
1. Real trade lifecycle now exists
Instead of:
enter → exit
Now:
entry → 1R → breakeven → 2R → trail runner
This is how real discretionary + systematic hybrids operate.
2. You are no longer dependent on perfect exits
first target locks profit
second target scales performance
runner adapts to trend continuation
3. Risk becomes stable over time
stop is fixed per trade
no emotional adjustment
trailing only activates after profit
4. Works best on:
ES 5m = smoother scaling
NQ 5m = stronger runner potential
15m = directional bias overlay (recommended above this)
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.